{
    "Trade/Device Name(s)": [
        "Cepheid Xpert\u00ae GBS LB Control Panel"
    ],
    "Submitter Information": "Microbiologics, Inc.",
    "510(k) Number": "K182472",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN150058"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "September 5, 2018",
    "Summary Letter Received Date": "September 10, 2018",
    "Submission Date": "October 18, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed quality control material for clinical microbiology assays"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Streptococcus agalactiae",
        "Lactobacillus acidophilus"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GeneXpert\u00ae Instrument System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid testing"
    ],
    "Methodologies": [
        "Extraction",
        "Amplification",
        "Detection"
    ],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert GBS LB Control Panel as external assayed quality control for nucleic acid detection of Group B Streptococcus on GeneXpert system",
    "Indications for Use Summary": "Intended for use as external assayed positive and negative quality control materials to monitor in vitro nucleic acid testing for qualitative detection of Group B Streptococcus using Cepheid Xpert GBS LB Assay on GeneXpert Instrument System",
    "fda_folder": "Microbiology"
}